1989
DOI: 10.1001/archinte.1989.00390110105024
|View full text |Cite
|
Sign up to set email alerts
|

A New Noninvasive Management Strategy for Patients With Suspected Pulmonary Embolism

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
38
0

Year Published

1991
1991
2003
2003

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 150 publications
(38 citation statements)
references
References 33 publications
0
38
0
Order By: Relevance
“…Therefore, the institution of long-term anticoagulant therapy without performance of pulmonary angiography is acceptable [6,9]. Pulmonary angiography should be reserved for patients with vital contraindications for anticoagulants or those in whom there is strong suspicion of the presence of a disorder other than pulmonary embolism.…”
Section: High Probability Perfusion-ventilation Lung Scanmentioning
confidence: 99%
See 3 more Smart Citations
“…Therefore, the institution of long-term anticoagulant therapy without performance of pulmonary angiography is acceptable [6,9]. Pulmonary angiography should be reserved for patients with vital contraindications for anticoagulants or those in whom there is strong suspicion of the presence of a disorder other than pulmonary embolism.…”
Section: High Probability Perfusion-ventilation Lung Scanmentioning
confidence: 99%
“…In a large prospective management study of 874 patients, deep vein thrombosis was detected using impedance plethysmography in 19%, 8% and 1% of patients with a high probability, non-high probability and normal lung scan result respectively [9]. Serial impedance plethysmography up to 2 weeks was performed in 371 patients with a non-high probability lung scan result, and deep vein thrombosis was detected in nine (2%).…”
Section: Non-invasive Tests For Venous Thromboembolismmentioning
confidence: 99%
See 2 more Smart Citations
“…Other important factors include the severity of preexisting cardiopulmonary dysfunction and the peripheral venous clot burden, which signifies the potential of recurrent thromboembolic events [15,33]. The interactions of these factors result in the development of pulmonary artery hypertension and right ventricular pressure overload.…”
Section: The Bleeding Risk Associated With Thrombolytic Treatmentmentioning
confidence: 99%